עקוב אחר
Janos Szebeni
Janos Szebeni
Nanomedicine Research and Education Center, Semmelweis University
כתובת אימייל מאומתת בדומיין seroscience.com
כותרת
צוטט על ידי
צוטט על ידי
שנה
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties
SM Moghimi, J Szebeni
Progress in lipid research 42 (6), 463-478, 2003
16042003
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity
J Szebeni
Toxicology 216 (2-3), 106-121, 2005
6972005
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions
A Chanan-Khan, J Szebeni, S Savay, L Liebes, NM Rafique, CR Alving, ...
Annals of Oncology 14 (9), 1430-1437, 2003
5452003
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention
J Szebeni, F Muggia, A Gabizon, Y Barenholz
Advanced drug delivery reviews 63 (12), 1020-1030, 2011
4882011
Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study
J Szebeni, CR Alving, FM Muggia
JNCI: Journal of the National Cancer Institute 90 (4), 300-306, 1998
4211998
Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals
J Szebeni
Molecular immunology 61 (2), 163-173, 2014
4112014
PEGylated liposomes: immunological responses
M Mohamed, AS Abu Lila, T Shimizu, E Alaaeldin, A Hussein, HA Sarhan, ...
Science and Technology of Advanced Materials 20 (1), 710-724, 2019
3822019
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
GT Kozma, T Shimizu, T Ishida, J Szebeni
Advanced drug delivery reviews 154, 163-175, 2020
3812020
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management
D Rampton, J Folkersen, S Fishbane, M Hedenus, S Howaldt, F Locatelli, ...
haematologica 99 (11), 1671, 2014
3152014
F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins
M Basta, F Van Goor, S Luccioli, EM Billings, AO Vortmeyer, L Baranyi, ...
Nature medicine 9 (4), 431-438, 2003
2932003
Poly (ethylene glycol) s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process
I Hamad, AC Hunter, J Szebeni, SM Moghimi
Molecular immunology 46 (2), 225-232, 2008
2922008
Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
Z Weiszhár, J Czúcz, C Révész, L Rosivall, J Szebeni, Z Rozsnyay
European journal of pharmaceutical sciences 45 (4), 492-498, 2012
2622012
Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
J Szebeni, P Bedőcs, Z Rozsnyay, Z Weiszhár, R Urbanics, L Rosivall, ...
Nanomedicine: Nanotechnology, Biology and Medicine 8 (2), 176-184, 2012
2572012
Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies
J Szebeni, L Baranyi, S Savay, J Milosevits, R Bunger, P Laverman, ...
Journal of liposome research 12 (1-2), 165-172, 2002
2452002
Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and …
J Szebeni, JL Fontana, NM Wassef, PD Mongan, DS Morse, DE Dobbins, ...
Circulation 99 (17), 2302-2309, 1999
2341999
Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles
J Szebeni, CR Alving, L Rosivall, R Bünger, L Baranyi, P Bedöcs, M Tóth, ...
Journal of liposome research 17 (2), 107-117, 2007
2312007
Methylation of the phosphate oxygen moiety of phospholipid‐methoxy (polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin …
S Moein Moghimi, I Hamad, TL Andresen, K Jørgensen, J Szebeni, ...
The FASEB journal 20 (14), 2591-2593, 2006
2302006
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction
J Szebeni, L Baranyi, S Savay, M Bodo, DS Morse, M Basta, GL Stahl, ...
American Journal of Physiology-Heart and Circulatory Physiology 279 (3 …, 2000
2202000
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
D Shi, D Beasock, A Fessler, J Szebeni, JY Ljubimova, KA Afonin, ...
Advanced drug delivery reviews 180, 114079, 2022
2102022
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents
J Szebeni
Critical Reviews™ in Therapeutic Drug Carrier Systems 18 (6), 2001
2022001
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20